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Abstract
Studying physiology and pathophysiology over a broad population for long periods of time is difficult primarily because
collecting human physiologic data can be intrusive, dangerous, and expensive. One solution is to use data that have been
collected for a different purpose. Electronic health record (EHR) data promise to support the development and testing of
mechanistic physiologic models on diverse populations and allow correlation with clinical outcomes, but limitations in the
data have thus far thwarted such use. For example, using uncontrolled population-scale EHR data to verify the outcome of
time dependent behavior of mechanistic, constructive models can be difficult because: (i) aggregation of the population
can obscure or generate a signal, (ii) there is often no control population with a well understood health state, and (iii)
diversity in how the population is measured can make the data difficult to fit into conventional analysis techniques. This
paper shows that it is possible to use EHR data to test a physiological model for a population and over long time scales.
Specifically, a methodology is developed and demonstrated for testing a mechanistic, time-dependent, physiological model
of serum glucose dynamics with uncontrolled, population-scale, physiological patient data extracted from an EHR
repository. It is shown that there is no observable daily variation the normalized mean glucose for any EHR subpopulations.
In contrast, a derived value, daily variation in nonlinear correlation quantified by the time-delayed mutual information
(TDMI), did reveal the intuitively expected diurnal variation in glucose levels amongst a random population of humans.
Moreover, in a population of continuously (tube) fed patients, there was no observable TDMI-based diurnal signal. These
TDMI-based signals, via a glucose insulin model, were then connected with human feeding patterns. In particular, a
constructive physiological model was shown to correctly predict the difference between the general uncontrolled
population and a subpopulation whose feeding was controlled.
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Introduction
Human physiology, as a science, aims to understand the
mechanical, physical, and biochemical functions of humans;
moreover, because human dynamics transpire both on multiple
spatial scales, ranging from molecular (e.g., genetics), to cell (e.g.,
metabolism), to organ (e.g., the heart [1]), to collections of organs
(e.g., the circulatory system) and on multiple time scales ranging
from fractions of a second to decades, it is likely that complete
models of human functioning will consist of highly complex
models whose scales interact in complex ways (e.g., via nonlinear
resonance) [2]. In this context, population physiology aims to
understand medium to long time scales of human physiology
and pathophysiology where a population of humans is required to
construct or discover a signal (metaphorically, population physi-
ology is to physiology as climatology is to weather). Moreover,
once a signal is constructed, the goal is to use this signal to
understand human dynamics by both understanding the sources of
the signals and then use that information to stratify the population
into meaningful classes (e.g., phenotypes) according to the different
signals. Consequently, population physiology, as we conceive it,
has two broad features: data analysis consisting of the construction
and analysis of population scale physiological signals, and the
mechanistic modeling that can explain and rationalize those
signals. The hope is that, through the use of EHR data, physiology
can eventually be used by clinicians in the same way that physics is
used by engineers. Thus, here we will employ diverse populations
in an attempt to verify that an EHR-data-derived signal can be
used to resolve first-order physiologic dynamics.
The mathematical modeling of physiological systems on the
cellular and organ scales has a long history (cf., [3] and [4] for a
wonderful introduction), while the modeling of larger scale organ
structures is just beginning [5]. Fundamental to mathematical
modeling of physiology is a concrete connection to real data; as is
the case for other basic sciences, mathematical physiological
modeling is always tested against physiological data collected in
rigorously controlled circumstances. Nevertheless, there are at
least two elements missing from modern physiological analysis,
analysis over large populations and analysis over long time periods.
The former is important because human beings have diverse
reactions to different inputs (e.g., drugs, foods, etc.), and those
differences have their roots in physiology. The latter is important
because many differences amongst human reactions to input occur
on a slow time-scale; for instance, some smokers develop cancer
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while others do not. The problem with using the classical
physiology framework with its rigorously controlled conditions to
study a large population over a long time period is that it is too
expensive, intrusive, and dangerous to collect physiologic data for
a large population over a long time period. Thus, it is likely that
the lack of availability of population scale, long term data is the
primary reason why wide-population, long term, physiologic
studies to not exist.
With the advancement of electronic health record (EHR)
repositories, the ‘‘lack of data’’ problem will be replaced with data
analysis and data mining problems. Electronic health records hold
data for large, diverse populations, and they cover periods of
decades [6] [7] [8]. Nevertheless, despite years of work, the
methods needed to exploit EHR data remain in their infancy. A
necessary realization for using EHR data is recognizing that the
EHR represents a natural system in its own right. In particular,
EHR data not only represents the physiology of the diverse
population being cared for, but also the following: healthcare
measurement dynamics (e.g., individual hospital protocols); the
local environment (e.g., exposure to pollutants); local customs (e.g.,
willingness to seek medical attention); and any other features of the
environment in which the data are collected. To see some of the
difficulties and potential associated with the analysis of EHR data,
consider four notably relevant examples: Sagreiya and Altman [9]
demonstrated the limitations of using general population EHR
data for estimating drug dosages; Hripcsak et al. [10] showed the
difficulties with using general EHR data for classification of disease
(i.e., community-acquired pneumonia); Karsh et al. [8] outlined
various factors that will constrain EHR data; and Higgins and
Mehadevan [11] demonstrated that relevant, predictive, phenom-
enological master equations of physiological functioning (concen-
trations of red blood cells) can be generated using data that could
exist in an EHR repository (note that in Higgins and Mehadevan
[11] the terminology population dynamics refers to a population of
red blood cells not humans) and that, if integrated into a EHR
infrastructure, would help with early prevention of disease (i.e.,
anemia). Advancing such methods is a step-wise process, and here
we present what we believe is an important early step: showing
that it is feasible to use EHR data in conjunction with a
constructive physiological model — specifically, that we can test a
physiologic model with an EHR data-derived signal.
To study how EHR data can be used in conjunction with a
physiological model, we consider the relatively simple problem of
glucose variation because it is easy to present and understand, it
has relevant, well understood models, and we know what the
answer should be. Specifically, we leverage the following tools or
data sets: (i) a subpopulation of patients with at least two glucose
measurements from an EHR that includes all inpatients and
outpatients seen at an academic medical center over 20 years; (ii)
two well sampled patients from the same previously mentioned
EHR; (iii) a set of particularly sick, continuously-fed (via a feeding
tube), immobile, comatose patients taken from the neural intensive
care unit (NICU) portion of the previously mentioned EHR; (iv) a
relatively simple mechanistic glucose-insulin model with various
different feeding patterns; and (v), the time-delay mutual
information (TDMI) which quantifies nonlinear correlation between
ensembles of measurements separated by a given amount of time.
Along with demonstrating that EHR data can be used to test
physiologic models for populations over long time periods, we also
discover that while human glucose levels are highly aperiodic,
there is nevertheless a stable, long term diurnal structure in the
nonlinear correlation between glucose values separated in time in
healthy, random humans. Moreover, while it is likely that many
features contribute to the observed diurnal cycle in correlated
glucose, only two interacting time scales are required to reproduce
the observed diurnal signal — a ‘‘statistically periodic’’ feeding
pattern that exists on the scale of weeks and the organ level
dynamics that exists on the order of minutes. Less broadly, we find
that: (i) to first order statistical moment (e.g., the mean), daily
variation in the TDMI is a function of feeding alone—no diversity
in other parameters that determine glucose/insulin regulation are
required; (ii) that glucose regulation acts like a control system on a
fast time scale (order of minutes) in contrast to kidney function
which behaves like a filtering system [12]; (iii) a diurnal signal in a
derived value, nonlinear correlation (TDMI), that can be used to
distinguish different populations; and (iv) it is possible to
circumvent inter-patient variability though aggregating popula-
tions, but one must be very careful interpreting the results [13].
Outline
We begin with a materials and methods section that has three
distinct components. In subsection 0.3 we discuss endocrine
physiology and introduce the mechanic model we use in this
paper. We then introduce electronic health record data in general
and the data we use in particular in subsection 0.4. The materials
and methods section concludes with a discussion of the nonlinear
time series analysis techniques we use (subsection 0.5). We then




This work was approved by the Columbia University Institu-
tional Review Board. Informed consent was waived by the
Institutional Review Board for this retrospective research.
0.2 Data assess statement
Unfortunately, the data for this study cannot be made publically
available because the detail and complexity of the data put it at
risk for re-identification. Similar data are publically available from
the PHYSIONET and MIMIC data repositories.
0.3 Glucose-Insulin physiology
0.3.1 Background: endocrine dynamics. Begin by noting
that a complete physiological understanding of the endocrine
system, or even the glucose/insulin cycle, has not yet been
achieved. For instance, how insulin reacts at the plasma
membrane of insulin sensitive cells is still poorly understood (for
other examples, cf., [14] [15]). With respect to diurnal cycles in
glucose/insulin dynamics, the following effects have been
observed: in fasting humans, there are wake-sleep cycle based effects
on pancreatic enzyme secretions [16]; physical activity has an
effect on insulin secretion [17]; and in rats there appears to be an
endogenous circadian oscillator (internal clock) located within the
pancreatic islets [18]. Most importantly, it is well understood that
nutrition intake is the primary first order driver of the glucose-
insulin cycle [17] (hence the need to use fasting humans as a
control to isolate the more sensitive glucose-insulin effects). All of
these studies were carried out under the classical physiology
framework. Moreover, to resolve many of the previously listed
signals required rigorous control of the measured individuals—
most EHR data will never meet these standards. But, the noted
contrast between classical physiology data and EHR data helps
clarify one of the goals of this paper: we are not trying to discover
an ultra-sensitive, controlled, physiological effect that is resolvable
over a short time period; rather, we are trying to discover what can
be resolved with EHR data. Specifically, we are trying to discover
Population Physiology
PLOS ONE | www.plosone.org 2 December 2012 | Volume 7 | Issue 12 | e48058
gross, long term, population-wide effects that have the potential to
help stratify populations into observably different types — types
that can eventually be linked to different health states. Moreover,
because the individuals within the EHR have observably differing
health states that do not require ultra-fine resolution to observe,
the hope is that we will be able to eventually use EHR data to
discover and categorize different, long term, physiologic macro-
states. This is the justification for not choosing the most
complicated glucose/insulin model. While the model we utilize
parameterizes away many of these higher-order effects, it remains
driven by nutrition, the source of the first order, elementary
glucose/insulin dynamics we are trying to verify.
0.3.2 First principles model of glucose-insulin
physiology. The first principles, constructive, mechanistic
glucose-insulin we use is presented in Sturis et al. [19] which















































where the state variables correspond to: Ip, plasma insulin; Ii,
remote insulin; G, glucose; and h1, h2 and h3 which correspond to
three parameterized delay processes. The major parameters
include: (i) E, a rate constant for exchange of insulin between
the plasma and remote compartments; (ii) IG , the exogenous
(externally driven) glucose delivery rate; tp, the time constant for
plasma insulin degradation; (iii) ti, the time constant for the remote
insulin degradation; (iv) td , the delay time between plasma insulin
and glucose production; (v) Vp, the volume of insulin distribution
in the plasma; (vi) Vi, the volume of the remote insulin


































lin-dependent glucose utilization. Note that a full list of the
parameters in this model, as well the model parameter settings
used in this paper, can be found in table 1; moreover, Keener and
Sneyd [4] provides a nice discussion of this particular model. With
the exception of the exogenous glucose delivery rates, which we
will discuss shortly, we utilize all the standard parameter settings
used in Sturis et al. [19]. Finally, there do exist more complex,
higher order glucose/insulin metabolism models [20], but because
the point was to choose the simplest system of ODEs that can be
used to represent the data-driven signal, we chose this rather
standard model.
The only part of the model we vary is the external driving, or
the exogenous glucose delivery rate, IG(t); specifically, we consider five
different feeding patterns. The first feeding pattern we consider is a
population that is fed continuously and where each member of the
population is fed at a different rate. This feeding pattern forms a
baseline for other continuous and periodically fed populations and
is denoted by the feeding function IG,cp. The data sets generated
with this feeding structure include 9 days of data collected by the
minute. The second feeding pattern is identical to the first with the
exception that 20% of the 9 days of data have randomly selected four
hour gaps where no food is administered. This feeding pattern is
meant to simulate an intensive care unit population and is denoted
by the feeding function IG,rcp. Both of these feeding patterns are, in
a sense, pathophysiologic. The other three feeding patterns are
based on simulated meals. To construct mealtime feeding
structure, begin by defining the set of meal times, specified by
the set M~fm1,    ,mng, where the mi’s represent times over a
24-hour interval, and n is the number of meal times within a 24-
hour period. Next define the exogenous glucose delivery rate at the







where Ij is the peak rate of delivery of glucose for a given
individual j at time mi, N~#fmivtcg represents the total
number of meals that have passed by time t, and k is the decay
constant (k~0:5). The decay constant is set such that the meal
persists over about two hours, a time that is considered realistic
[19]. Next, relative to the m1~8, m2~12, and m3~18, define the
following three feeding patterns: periodic individual,
Mpi~½m1,m2,m3; noisy individual, Mni~½m1zn1(k),m2zn2(k),
m3zn3(k) where ni(k) is a uniform random variable on the
interval ½{1,1 and k represents an integer day (implying that ni
changes every day); and random individual, Mri~½n1(k),n2(k),n3(k)
where ni(k) is a random (non-repeated) integer on the interval
½0,23 and k is again an integer day (implying that ni changes every
day). Based on these meal structures we define five feeding
patterns, continuously fed population (IG,cp), continuously fed population
with random gaps (IGrcp ), a periodically fed individual (IG,pi), a noisy-
periodic individual (IG,npi ), and a random individual (IG,ri ), defined
formally as:
IG,cp~Ij constant [½100,225 mg=min ð8Þ






t{mi ,I~216 mg=min, mi[Mpi ð10Þ
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t{mi ,I~216 mg=min, mi[Mri ð12Þ
These five different driving mechanisms reflect what we believe to
be a relatively minimalistic amount of variation within the
glucose/insulin model parameter and function space.
0.3.3 Endocrine dynamics as a control system. To
interpret the results, it will help to abstract the physical
mechanisms to a control system. In particular, the regulation of
glucose can be thought of as an intra-body feedback control system
where the body has a goal of maintaining a constant concentration of glucose
and attempts to achieve this goal via various physiological
mechanisms [21]. Broadly, when glucose levels are high, insulin
is released by the pancreas leading to glucose being stored in the
liver faster than it is released and the rate at which glucose is
metabolized by the body is increased. Similarly, when glucose
levels are low, glucagon is released by the pancreas, allowing for an
increase in the rate glucose is released from the liver as well as a
decrease in the rate glucose is metabolized by the body. This
contrasts with, for example, the kidneys and their relation with
creatinine, which can be grossly thought of as a filtering system
instead of a control system aiming at maintaining a particular level
of glucose. (Note, there are parts of the kidney that do behave as a
control system [22]). It is worth mentioning that the above
description of the endocrine system is greatly simplified, (for a
more detailed view, cf. [23] [24]).
0.4 Data composition
We consider the time series of glucose measurements of two real
populations of humans extracted from the Columbia University
Medical Center (CUMC) EHR: (i) the time series of glucose
measurements extracted from an EHR for all inpatients and
outpatients over 20 years (800,000 patients with roughly
12,000,000 glucose measurements); (ii) the time series of glucose
measurements for a small subset of patients (43 in total) seen in the
NICU who are continuously fed, immobile, and comatose—note
that this cohort of patients is represented by between 4 and 193
measurements taken on the order of minutes to hours (many
patients have approximately a weeks’ worth of hourly measure-
ments). Finally, it is important to note that glucose is measured in
many contexts, many of which include situations where glucose is
not the primary target (e.g., the CHEM-7 metabolic panel, which
includes glucose, is taken in many situations where glucose is not
primary chemical of interest).
The data sets we chose are of varying size over populations,
numbers of points, and time periods. Nevertheless, the population
size is not explicitly important. Rather, it is the number of data
points used to compute the given quantities that are of explicit
importance. Specifically, the number of points are important
because the errors or estimation biases of computable quantities
(e.g., averages, TDMI, etc.) depend on the number of points, (cf.
Albers and Hripscak [25] for a description for TDMI). Because
EHR data are special in that it is not collected in a controlled
Table 1. Full list of parameters for the glucose/insulin model [19] used in this paper.
Glucose model parameters
Parameter nominal value meaning
Vp 3 l plasma volume
Vi 11 l insulin volume
Vg 10 l glucose space
E 0:2 l min21 exchange rate for insulin between remote and plasma compartments
tp 6 min time constant for plasma insulin degradation (via kidney and liver filtering)
ti 100 min time constant for remote insulin degradation
td 12 min delay between plasma insulin and glucose production
Rm 209 mU min
21 linear constant affecting insulin secretion
a1 6:67 exponential constant affecting insulin secretion
C1 300 mg l
21 exponential constant affecting insulin secretion
C2 144 mg l
21 exponential constant affecting IIGU
C3 100 mg l
21 linear constant affecting IDGU
C4 80 mU l
21 factor affecting IDGU
C5 26 mU l
21 exponential constant affecting IDGU
Ub 72 mg min
21 linear constant effacing IIGU
U0 4 mg min
21 linear constant affecting IDGU
Um 94 mg min
21 linear constant affecting IDGU
Rg 180 mg min
21 linear constant affecting IDGU
a 7:5 exponential constant affecting IDGU
b 1:77 exponent affecting IDGU
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environment, the EHR represents a population whose individuals
are both diverse and measured diversely. Often only a small
percentage of the population has the required characteristics for
computation. Similarly, sometimes many sparsely measured
individuals can be aggregated such that the aggregated population
can accurately represent a single well-measured individual.
Because of this, 100,000 sparsely measured patients can essentially
represent 100 well measured patients. In all cases, the numbers of
patients we have selected are arbitrary numbers that are large
enough to compute trustable quantities.
0.4.1 EHR population. The first data set, the EHR patients,
is not filtered or carefully selected in anyway; we chose to use the
entire EHR population for five reasons. First, we want to
demonstrate the generality of the first order effects on glucose
variation; specifically, our results are not sensitive to many
confounders that one might imagine. Second, we wanted to how
the robustness (i.e., stability of the computation) of our time series
analysis methodology on real EHR data, despite all the
measurement complexities present. Third, we wanted a population
that, upon considering higher order effects, would have the
potential to be stratified into different types or categories. Fourth,
because EHR data are extremely complicated, we did not want to
build in any more a priori notions of signals than were absolutely
necessary. And fifth, because EHR data are not carefully collected
physiologic data, to interpret EHR-data-driven results we must
understand what EHR-based biases exist, and we cannot observe
unknown EHR-specific biases when we choose a carefully
manicured data set. Or, written differently, one of the purposes
of this paper is to demonstrate how to derive a signal that is not
sensitive to the alignment of patients, noisiness of feeding
schedules, and other EHR-specific randomness, yet conveys useful
information for population.
Because we use a very broad population, it is important to
comment on the complex nature of the composition of the EHR
data as a data source. To do demonstrate this, as an example,
consider the hypothesis that diabetics would have the most
frequently recorded glucose values. A careful verification of this
hypothesis is both a substantial research question, and is out of the
scope of this work. Nevertheless, we can make a bit of an inference
into the validity of such a statement. Among the 100 most
measured patients in the CUMC EHR, 75% have at least one
billing code for diabetes [13]. In contrast, if one considers a
random set of patients, the proportion that have several glucose
measurements within 6 hours of one another who have at least
one billing code for diabetes falls to 50% [13]. Meaning, within the
general population of patients who are sampled at least as
frequently as once every 6 hours, at least half are not diabetic. One
can imagine many plausible reasons for this; one example might
be that a substantial portion of the glucose measurements come as
part of a panel with other measurements in which case many of
the glucose measurements would be measured as part of a routine
for caring for particularly sick patients, such as patients admitted
for congestive heart failure. Related issues regarding over or
underrepresentation are difficult to address because of the
relativity of the expected rates of measurement. In the United
States, 8:3% of the population (as of January 2011) had diabetes,
thus assuming a uniform measurement of glucose of US residents,
diabetics are overrepresented in our data. It is unknown whether
they are over or under measured relative to desired clinical
protocols. Nevertheless, the data set we use contains a large
number of both diabetic and non-diabetic patients who have
frequent glucose measurements so features of intra- and inter-
group dynamics are resolvable.
In addition to the random EHR population, we have included
two relatively well measured patients from the CUMC EHR. We
have included these patients to demonstrate that, despite potential
population-aggregation effects on glucose variability (recall that
Albers and Hripcsak [12] detailed how aggregation of different
sources can affect a TDMI signal), the results we observe are
present in well measured individuals too. This decreases the
likelihood that our results are confounded by population
aggregation alone. These patients were selected from among the
100 patients with the most glucose values in the CUMC EHR and
they represent the two typical types of patients; the TDMI analysis
of this subpopulation and others can be found in Albers et al [13]
[25]. Both patients were sick, with different illnesses, and were
hospitalized during some, but not most, of their measurements.
Neither patients’ glucose measurements come primarily from the
ICU setting. Among this set of patients, there is not very much
variation in the TDMI signal; we chose one patient (whose record
is roughly 3 years long) with the weakest signal and one patient
(whose record is longer than 15 years) with a signal of average
strength among this set of 100 patients. Note that even the set of
100 patients with the most glucose values is remarkably diverse
when considering the notes for the patients. Some of the afflictions
among this set of patients includes: pancreatic cancer, chronic
kidney disease (CKD) (some CKD patients have type 1 or 2
diabetes and some do not), organ transplants of various types, type
1 or type 2 diabetes with various degrees of compliance with
treatment, congestive heart failure, etc. Moreover, about 75% of
these patients are presumed to be diabetic (either type 1 or 2). Due
to the complexity of the models and patients, resolving the source
of the higher order features of the TDMI distribution (e.g., the
higher order moments) of the 24-hour TDMI peaks among
patients is beyond the scope of paper.
0.4.2 Neural intensive care unit subpopulation. The
NICU population is a much more narrow population, and
because this population is acting as a control in some sense, it is
important to detail their nutrition in a more detailed fashion. The
entire set of 43 patients was administered enternal nutrition (i.e.,
via a feeding tube) starting within 24 hours of aneurysmal repair
[26]. While the enternal nutrition was continuous when given
(denoted continuous feeding), there were random episodic gaps
where nutrition was withheld (random Nil per os (NPO)).
Specifically, the feeding is suspended before invasive procedures
(e.g., surgery, extubation), when there are high gastric residuals
(i.e., when there is a lot of residual food left in the stomach), when
there exists intestinal obstruction (ileus), and when the patient has
diarrhea or is aspirating the food. The existence of these random
gaps in nutrition are the reason why one of the model populations
is continuously fed with random feeding gaps. The enternal
nutrition was the primary source of nutrition (less than 10% of the
caloric intake came from other sources such as drugs). The
primary target for each patient was 25cal=kg (or 70cal=hr) and
the primary caloric source was Osmolite. The NICU population
does receive insulin; how and why is complex and is discussed in
detail in Schmidt et al. [27]. We do not attempt to control for
insulin because it is difficult to foresee whether it matters; our
results will show that the insulin regimen in the NICU population
does not affect our results to first order in statistical moment (i.e.,
the mean). Finally, note that within the NICU population, less
than 10% of the patients are diabetic; removing them does not
alter the results.
0.4.3 Contrasting the two patient populations. Con-
ceptually, there are four important differences in these popula-
tions: (i) the EHR broad population is uncontrolled and
monitored poorly (it is the general patient population after all)
Population Physiology
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whereas the NICU population is highly controlled and monitored;
(ii) the EHR broad population has an unknown and uncontrolled
feeding pattern whereas the NICU population is being fed
continuously and in a very controlled and documented fashion;
(iii) the EHR broad population represents a diverse set of humans
with diverse and unknown health states whereas the NICU
population represents a very sick population whose degree of
acuity is considerably higher and more narrowly defined than that
of population one; and (iv) while the detailed understanding of
metabolic function is unknown in both populations, it is very likely
that the metabolic functioning of patients in the NICU population
is substantially more compromised. Thus, the NICU population
functions roughly as a control to isolate the effects of continuous feeding on
glucose daily variability because this population has relatively few
normal external physiological forcing mechanisms (e.g., sleep
cycle, daily exercise, real mealtimes, etc.). In contrast, the broad
EHR population is meant to represent the population at large
whose feeding pattern is uncontrolled, highly discontinuous, and
has unknown regularity.
0.5 Computational methods
We use two diagnostics for the EHR and model glucose time
series, (i) intra-patient normalized glucose by hour, and (ii) the
TDMI of the glucose time series (Albers and Hripcsak [13]
explains how the TDMI can be applied to a population). It is
important to note that the reason we chose the TDMI is that,
when applied to a population, it affords the eventual possibility of
stratifying patients by predictability (cf. conjecture one in Albers
and Hripcsak [13]).
With respect to (i), we normalize each patient to mean zero and
unit variance, and then calculate the mean and variance of glucose
by hour over the population. We do this because there is a high
degree of individual variability within each population, and
individuals were measured differently from each other. Therefore,
to resolve a property such as the by-hour daily variation of glucose
values, we must remove inter-individual variation. Without this
correction, inter-individual variation and therefore population
aggregation effects became the first order effects. Nevertheless, we
will show the normalized glucose variation for an individual
patient to demonstrate that individuals mimic the population.








where xt and xt{dt represent an ensemble of all the intra-patient pairs
of points in the population of time series separated by a time dt and p(:)
denotes the probability density function (PDF) of those ensembles;
note that the TDMI captures linear and nonlinear correlations in
time, which differs from, say, auto or linear correlation calcula-
tions (to see this applied to kidney function, see Albers and
Hripcsak [12], and for general application, see Albers and
Hripcsak [13]). Finally, to calculate the TDMI, one must estimate
the joint and marginal PDFs, here we used a kernel density
estimation (KDE) routine [30] implemented on MATLAB.
In general, the TDMI is a unit-less quantity; a TDMI of 0
(within bias) implies that there is no correlation between sequential
values in a time series for a given dt. TDMI values begin to
become important when they exceed the expected bias associated
with calculating the mutual information, which is approximately 1
M
where M is the number of pairs of points used to estimate the
TDMI (*0:001 in this experiment). With a perfect correlation
between sequential values, the TDMI will be equal to the entropy
(or auto-information) of the series, which is numerically equal to
the TDMI at dt~0 (and is calculated automatically as part of the
experiment). In this experiment the entropy was about 0:85 and
represented the maximum TDMI. (In most of our experiments,
the entropy is in the 0:5 to 2 range.) Note that perfect correlation
of a constant function (implying PDFs that are d functions) yields a
TDMI of zero for all dt.
With respect to the models, the ODEs were integrated over
time-periods ranging from seven days to three weeks. A standard
fourth-order Runga-Kutta integration routine, with a step-size of
10{4, was utilized.
Results
0.6 Basic physiological synopsis
Figure 1 details the feeding-glucose response for the models.
The point of this figure is to depict the basic building blocks that
will be aggregated into a population. Figure 1(a) demonstrates
that, relative to the model, a continuous infusion of glucose induces a
periodic oscillation in intravascular glucose whose period is on the
order of minutes; note that verification of this signal in humans can
be found in Fig. 1 of Sturis et al. [19] or more generally in Lang et
al. [31]. Furthermore, note that in this case the glucose oscillation is
exactly symmetric about its mean, implying that long term averages of
the glucose-insulin response should be a constant — this fits with
the intuitive control theory vision of the glucose-insulin cycle.
Figure 1(b) illustrates the glucose oscillation structure that is
induced when the feeding pattern consists of three realistic meals
given at 8, 12, and 18 hundred hours respectively. Note that the
peaks and length of time over which the glucose response exists
depends on the magnitude of the calories in the meal — one way
of conceptualizing this system is as a forced oscillator with
damping that depends on caloric input and metabolism. Also note
that the when caloric intake is a pulse, the glucose-insulin response
is not exactly symmetric about the mean or baseline. In particular,
isolating the glucose response and integrating the response relative
to the baseline yields a very small but negative number, meaning
that the overall glucose level is depressed when integrated over the
course of the meal and response relative to this model.
0.7 Diurnal variability of glucose in a population
With the basic building blocks of glucose-insulin response in
place, next consider Fig. 2 which details the hourly glucose
variability within the data sets and models. In particular, in
Fig. 2(a) the hourly glucose variability for the EHR population
displays no observable diurnal variability or signal. While we expected
the short-term oscillations to average out we also expected to
observe a small but statistically significant signal on a 24-hour
cycle that matched meal times. More specifically, we expected a
small diurnal signal because: (i) humans eat periodically, which,
intuitively, implies that glucose would be broadly higher over meal
times; and (ii), there exists a weak but present diurnal variability in
kidney function that was observed on the same data set [12] —
which was surprising in and of itself because kidney function is not
normally believed to have a strong diurnal signal.
Before we give a more technical explanation as to why we,
equipped with the constructive model, would not expect to see any
diurnal variation in raw glucose values when averaged over a
population, it is important to compare the data-based signals in
Figs. 2(a) and 2(b) with the modeling results shown in Fig. 2(d) to
draw a few observations/conclusions. First, constant feeding in the
model for a population leads to constant (averaged by hour)
glucose which agrees with the data-based result (NICU patients) of
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Fig. 2(b), and thus verifies that relative to hourly glucose
variability, the model correctly predicts the observations. Of
course, because many feeding patterns produce the same signal in
hourly glucose variability, this does little to verify that the model
represents the endocrine system faithfully — to achieve this we
need a different, less ambiguous data-driven signal. Second, the
periodically driven individual has the expected daily meal response
structure; but the signal is too clean to realistically represent an
individual or a population because the meals are given at exactly
the same time every day. Third, the random feeding produces no
diurnal signal and thus agrees with the data-based result (random
population) from Fig. 2(a), meaning that it is possible either that
the model does not depend on strongly on feeding structure or that
the by-hour glucose is not good enough to detect feeding structure
and differentiate the respective populations. In the section that
follows, we demonstrate that the second statement is the correct
conclusion. Fourth, the noisy periodic case has wide, weak diurnal
peaks at meal times, which differs from what is observed in the
data; however, the primary reason the diurnal structure in daily
glucose variability is retained in the models with noisy periodic-like
feeding is that the meals are uniformly distributed within two hour
disjoint intervals. We know from further experiments that
increasing the diversity of the location of the mealtime windows between
individuals, while retaining the noisy mealtime structure within individuals,
allows the model results to reproduce the population signal shown
in Fig. 2(a) more faithfully. And fifth, considering the model output
shown in Fig. 1(b) where the glucose-insulin response to a meal is
roughly symmetric about the baseline glucose level.
Armed with the above information, we can now make a more
technical argument as to why there is no signal in the hourly
variation of glucose. The simplest explanation for the lack of
observed diurnal signal in hourly glucose values relies on four
observations, (i) we are aggregating/averaging many sparsely
measured sine-wave-like signals whose periods are much shorter
than an hour (that they come from many or a single patient is
largely irrelevant), (ii) these averaged waves have random starting
times, (iii) the averaged waves have different periods (e.g., because
patients are diverse), and (iv) the averaged waves have are
symmetric about their means (which are normalized to zero). Such
signals, when averaged, will yield a constant function. To see why
this is the case, consider a collection of sine waves that have
different periods whose average converges to something finite; the sum
of those sine waves will converge to 1
n
, where n is the number of
sine waves being averaged. This does not mean that there isn’t a
diurnal dependence within glucose (in fact, we find there is using a
derived value), or the glucose/insulin response following a specific
meal isn’t observable within EHR data, because it is. But, when one
averages over time, even for an individual patient who is not being
tube-fed (cf. Fig. 2(b)), variation in the daily average glucose is not
observable because of the noisy meal schedules (which affect
phases, periods and amplitudes), the act of averaging, the structure
of the glucose/insulin response to food (the response is order
minutes not hours), and the course resolution of measurement.
One can imagine more complicated reasons for why there is no
signal in Figs. 2(a) and 2(b), but the simple answer without
complicating factors (e.g., diabetes, NPO, acuity) — that
aggregation/averaging plus the dynamic type obliterates any
signal — is enough to remove the signal in the EHR population,
individuals, and all the models. Thus, these other complications,
while acting as possible contributors to the lack of signal, are
neither necessary to remove the signal, nor observable given only
the raw glucose values.
0.8 Diurnal variability in nonlinear correlation of glucose
Finally we arrive at the nonlinear-correlation variability in
glucose as quantified by the TDMI. Figure 3(a) frames the TDMI
over an entire seven day time-delay window and can, in a sense, be
split into two dynamical regimes, the TDMI for dtv12 hrs and
for dtw12 hrs. To highlight this difference, and to aid readability,
Figs. 3(b) and 3(c) are Fig. 3(a) split at dt~12 hrs. As previously
stated in 0.5, it is possible to use the distribution of the TDMI to
stratify the population at a given dt; here we will refrain from
analyzing these higher order (relative to the distribution moment)
effects and instead concentrate on the first order effects as defined
by the mean TDMI values that are shown in Figs. 3(a)–3(c). To be
clear, note that Fig. 3 contains the TDMI signals from both EHR
data (the random EHR population, the two individual patients,
and the NICU population) and model output (there is a TDMI
signal corresponding to each of the feeding patterns introduced in
section 0.3). Thus, we are explicitly comparing the TDMI signals
of the EHR data sets against themselves as well as the TDMI
signals of the model output. With this in mind, the following
features of Figs. 2-2 are of note: (i) all models and data sets show a
sharp decay in TDMI between one and twelve hours; (ii) one of
the individual patients has weak diurnal peaks in the TDMI at 24
and 48 hours while the other patient has diurnal peaks for several
days; (iii) the NICU population shows no long term structure in
the TDMI, although there does remain a constant amount of
TDMI present; (iv) the uncontrolled EHR population shows
diurnal peaks in the TDMI, and the magnitude of these peaks
decays with time; (v) the continuously fed population model, after
the decay within twelve hours, shows a weak hump at eighteen
hours that is a function of the exact symmetry of the periodic
oscillations in glucose, followed by a decay to small, constant,
TDMI — thus, this model case accurately represents the NICU patients; (vi)
the periodic individual model patient without noise has a good deal
of TDMI as well as sharp diurnal peaks and — note that from this
it is self-evident that an individual patient with a continuous
feeding regimen would also have a high level of TDMI, albeit
without the sharp 24-hour peaks; (vii) noisy periodic model has,
after the sharp decay at twelve hours, diurnal peaks in the TDMI
with non-decaying magnitude — thus, this model mostly closely represents
the real EHR population, and in fact the two overlay up to about 36 hours;
(viii) the TDMI for the randomly fed model case has no long
term structure — thus, the TDMI helps distinguish the constant feeding, the
random feeding, and the noisy periodic feeding models. To consider more
detailed analysis, it is instructive to split Fig. 2 into two regimes,
dtv12 hrs, and dtw12 hours.
The most important feature of Fig. 2, which shows the TDMI
for dtƒ12 hrs, is that the collection of TDMI curves are bounded
from above by the random feeding and below by the population with continuous
feeding models respectively. The random meal case has the most
TDMI within the first 12 hours because the random feeding case
maximizes the amount of observed TDMI per mealtime period.
This maximization occurs for two reasons: (i) isolated meals have
a large amount of TDMI that persists over approximately four
hours; and (ii), meals are uniformly distributed over the 24 hour
period and are unlikely to overlap. Said simply, the TDMI for the
random meals population with dtv12 largely represents the pure
intra-meal TDMI, which is the maximum TDMI amongst the
models (and apparently real populations) we examine. This
argument is further backed-up by the fact that the randomly fed
population has the sharpest decay in TDMI. The reason why the
TDMI for the population of continuously fed patient model is a
lower-bound is due to a combination of aggregation effects and
superpositions of periodic orbits. To understand this, recall Fig. 1(a)
and note that each member of the population of continuously fed
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patients will have orbits with different amplitudes and frequencies and
that aggregating them together at a given dt will produce a
distribution that will closely resemble a uniform distribution — the
distribution that minimizes TDMI over all distributions. All the
other cases fit in between these two extreme situations.
The longer the time (separation) scale is shown in Fig. 3(c) and
includes the TDMI for all cases over time-separations of 12 to
72 hours. Begin by noting that there is no structure in TDMI
signal for the NICU population as well as the random feeding and
continuously fed population models. Thus, using only the TDMI
and the normalized hourly glucose, it is difficult to distinguish the
continuously fed population from the randomly fed population. In
contrast, the EHR population, by displaying the diurnal peaks, is
easily distinguishable from the NICU population; thus the TDMI
helps distinguish the EHR and NICU populations in a way that
analysis of the raw glucose values could not. Moreover, because
Figure 1. Depicted above are (a) the glucose for the standard glucose-insulin model with continuous feeding; and (b) the glucose
for the standard glucose-insulin model with realistic meal structure. (a) Glucose-insulin model with continuous feeding and glucose
response. (b) Glucose-insulin model with three meals and glucose response.
doi:10.1371/journal.pone.0048058.g001
Figure 2. Depicted above are (a) the mean and standard deviation in glucose, by hour, for 800,000 patients whom have been
normalized to mean zero and variance one, with at least two glucose measurements from the CUMC EHR; (b) the two individual
patients mean and standard deviation in glucose measurements by hour, note the variability in patient 2 for which there are far
fewer measurements than for patient 1; (c) the mean and standard deviation in glucose and enteral (i.e., tube) feeding rates, by
hour, for 43 normalized patients in the neural ICU; (d) glucose, by hour, for various different model feeding patterns. (a) Normalized
population glucose by hour. (b) Single patient normalized glucose by hour. (c) Normalized NICU population glucose and feeding by hour. (d)
Normalized model glucose by hour.
doi:10.1371/journal.pone.0048058.g002
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the noisy feeding and EHR populations strongly resemble one
another (they are nearly identical for dt~½6,36 hours), and
because the exactly periodic feeding yields far to much TDMI, the
difference between the EHR population and the NICU population is likely due
to noisy, but specifically structured (i.e., not totally random) meal times. This
conclusion both confirms that EHR data reproduces what is
believed to be the first order glucose dynamical effect, nutrition,
and verifies that the ultradian model can represent humans for
much longer time scales than hours to minutes. Finally, even the
individual patient with the weakest signal shows a peak at 24 hours
and a weak peak at 48 hours, which is consistent with the EHR-
based TDMI signal.
0.9 Resultant synopsis
Based on Fig. 3(c), the most basic and elemental result is thus: the model
output can be used (in conjunction with the TDMI) to correctly predict the
distinction between general EHR patients and NICU patients on time scales
longer than a day. Moreover, the observed TDMI signal for the EHR
population represents noisy, but structured meal times over the population;
meaning, we can detect human behavior patterns in EHR data and test them
against physiological models. That is, adjusting the feeding in the
model alone was enough to account for the difference in the
observed TDMI signals and thus to distinguish the populations to
first order in statistical moment (i.e., mean TDMI), all without
injecting difference (e.g., differences in mean age) into the
parameters. This implies that EHR data can at least resolve some
first order physiological effects. At a finer resolution, while the first
order moment of the TDMI (i.e., predictability) can be used to
separate the two populations of patients because of how nutrition
is ingested, understanding the second order moment (i.e., the
variance of the TDMI peaks for a fixed dt) is more complicated
and is beyond the scope of this paper. More explicitly, it is likely
that the higher order moments of the TDMI peaks will depend, to
some unknown level of detail, on the health state of the patient.
Moreover, because even narrow EHR populations are relatively
diverse and as yet unquantified in the context at hand, and
because even the simple model we used has about 20 parameters
that we hold fixed for all populations examined here that are
nevertheless are available for variation, resolution of the higher
order moments of the TDMI peak is beyond the scope of the
current paper. Nevertheless, preliminary analysis seems to point to
the TDMI being monotonically dependent on nutrition and the
functioning (or artificial regulation) of the pancreas. We were able
to use EHR data to test a physiological model for a population,
but, as is the case with many other data-driven fields, derived
values (i.e., the TDMI) were more helpful than the raw values.
Finally, the relatively simple constructive glucose/insulin model
can accurately represent a population over much longer time periods than it was
designed to represent. Or, more specifically, while the model we use
here is an ultradian model designed to be applicable on a time-
scale of much less than a day, the model nevertheless appears to be
applicable over time periods considerably longer than a day.
Discussion
0.10 Summary discussion
The end goal of population physiology is twofold: (a) we want
to derive population-scale, data-based signals over medium to long
time-scales in a way that can be connected to constructive,
mechanistic models to further the understanding of human
physiology; and (b) we want to be able to use these verified,
constructive, mechanistic models to affect the health of human
beings via clinical care. In this paper, we have demonstrated (a)
but not (b), primarily because glucose/insulin modeling is not yet
at a stage were it can be applied to affect clinical care in a direct
manner. Nevertheless, we have begun one of the necessary steps
for implementing (b): we have demonstrated that a mechanistic
model of endocrine dynamics can accurately represent humans
over the longer time scales that are relevant to clinical outcomes.
Scientifically, the results in this work demonstrate and imply
that: (i) the output from a simple glucose/insulin model can be
used to predict the difference between EHR and NICU patients
over time periods longer than a day; (ii) glucose measurements for
a population yield diurnal variation in correlation, but glucose
dynamics behave in a way (i.e., oscillations about a mean whose
period is order minutes) such that diurnal variation in raw glucose values
is difficult to observe; (iii) ‘‘self-fed’’ humans do have a diurnal
TDMI signal in glucose; (iv) ‘‘normal’’ human glucose values do
display an initial decay in correlations (between subsequent
measurements) to a relative baseline within 12 hours; (v) the
models with the noisy but structured meal times match the diurnal
TDMI EHR signal, thus the diurnal cycle in predictability of
glucose is primarily driven by nutrition (not an internal clock); (vi)
EHR data can resolve a signal that spans multiple time scales and
can be used to test physiological models; (vii) that the standard
glucose/insulin model [19] is applicable beyond the time-spans it
was designed for; (viii) the NICU population and continuous
feeding model TDMI signals match one another — in particular,
humans being fed continuously do not have a diurnal TDMI signal
or any structured signal at all; and (ix) EHR data resolves human
social behavior — a meal time structure influencing glucose
physiology.
0.11 Potential impacts of integrating EHR data with
mechanistic models
There are two broad avenues through which the the integration
of mechanistic, constructive models with EHR-data can help
advance clinical care, data assimilation (and control theory) and in
silico experimentation.
First, given a mechanistic model, incorporating data into the
model to forecast the future is done using data assimilation [32]
[33]. To control the system all that is needed is an addition (the
controller) that codifies a desired outcome and a means of
achieving it relative to the parameters that are available for
adjustment. Data assimilation has not been used in this context,
control theory has a limited history in biomedicine but is emerging
as an important technique in a clinical context.
Data assimilation (DA) (e.g., a Kalman filter), combines observed
data from the current (and often the past) state(s) of the system with
underlying dynamical principles governing the system (i.e., a
constructive model) to make an accurate estimate or forecast of the
true state of the system at any given time, including variables that were
not measured. The DA prediction is referred to as an analysis. This
analysis output is fed back into the model to make a prediction or
forecast about future state of the system. Therefore, from a more
practical standpoint, DA schemes perform two functions: (i) they
reconstruct the state variables of a model, including both observed
and unobserved variables; and (ii), they forecast the future in a
way that can be directly tested with future measurements (and
used to implement control theory). Thus DA schemes are the
explicit way that data are injected into constructive models such
that predictions and forecasts can be made. This allows for
‘‘patient forecasts, ’’ where different outcomes can be based on
current and future observations and/or hypothetical data, thus
allowing for exploration of ‘‘what if’’ scenarios with patients. This
in turn allows us to take a more personalized view of treatments for
patients in clinical applications. Finally, some DA schemes (e.g.,
unscented Kalman filters) allow for ‘‘empirical observability,’’ or
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the ability to rank which variables are the most useful for
reconstructing the other variables, thus allowing us to determine
the most useful clinical variables, in some sense. Sedigh-Sarvestan
et al [38] applies a DA applied to the model in this paper that
includes empirical observability ranking of parameters and
variables.
Control theory [33] [34] [21] [35] applied to solve biomedical and
clinical problems has a very successful but limited history. Recall
that traditionally control theory has been used in engineering in
diverse contexts ranging from cruise control in a car to stabilizing
and flying jet aircraft to optimizing manufacturing processes.
Examples in biomedical contexts include implantable cardiover-
ter-defibrillator or pacemakers to cope with irregular heartbeats,
work toward creating an artificial pancreas [36], and to design
treatments for prostate cancer [37]. To apply (optimal) control
theory to any problem, one usually requires three components, an
explicit model of the process to be controlled (e.g., the glucose/
insulin model shown here), a statement regarding the constraints
of the system (e.g., fixed or disallowed parameter settings, initial
conditions, boundary conditions, etc.), and specification of the
performance (e.g., how tightly one wants to control glucose) [34].
EHR data will likely be the only data available on a population
scale that can be used to test a models, specify the constraints, and
specify the desired performance (based on retrospective EHR-data
Figure 3. Depicted above are (a) the TDMI curves for all EHR-data based populations and model output for all feeding patterns
resolved to one hour intervals for time delays of up to one week, note the sharp decay in TDMI in all cases, and the diurnal peaks in
all periodically fed populations or models — note this plot is split into dynamical regimes in Figs. 2 and 2; (b) the TDMI curves for all
populations and models over time-delays of 1 to 12 hours; and (c) the TDMI curves for all populations and models from 12 to
72 hours, notice the diurnal peaks in all periodically fed populations or models. Recall that the model feeding patterns are given
by: IG,cp — continuously fed population; IG,rcp — continuously fed population with random 4 hour gaps; IG,pi — periodically fed
individual; IG,ni — noisy-periodically fed individual; and IG,ri — a randomly fed individual. (a) All data sets and models — a global view of
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based study) based on desired outcomes. With a control theory
infrastructure in place for a given physiologic system applications
are very broad. For instance, one could design a controller to
regulate glucose in an ICU setting (cf. Sedigh-Sarvestan et al [38]
where the an unscented Kalman filter is applied to the model in
this paper), one could use the controller to design optimal
treatment strategies over long periods of time for outpatient
diabetics, or one could design artificial organs such as the artificial
pancreas project [39] [40] [41]. But these possibilities are only
possible in practice when we have a constructive model available.
Second, if a constructive model is good enough, and can be
verified well enough, it can be used to test new drugs and
treatments even without data (e.g., outside of a personalized
medicine approach where data assimilation is used). Such a
situation is referred to as in silico experimentation, and it has
already begun in some contexts. For example, recently an
endocrine model of the type 1 diabetes, being used in the context
of developing an artificial pancreas [36], has been approved by the
FDA as a substitute for animal trials for preclinical trials [41] [39]
[40]. In this case, artificial data are created (based on real data, but
not a DA analysis), and then different treatment strategies are
tested. This approach has the potential to greatly accelerate the
rate of advancement of therapy in many different contexts.
0.12 Looking forward
Looking forward, population physiology suffers from the lack of
existent, time-dependent signals; discovering such signals that can
be related to physiological models is where many current opens
problems lie. Said differently, before one can go about refining
models and understanding dynamics mechanistically and over
longer time periods, one needs actual data-based signals, or
stylized facts [42], that can suggest and motivate refinements in the
models via testing of those models before DA or control theory can
be applied. Moreover, we need to approach defining populations
by their dynamics from two directions, stratifying populations by
known characteristics (e.g., presence of type 1 or type 2 diabetes)
and observing signals and constructing signals, and using those
signals to stratify populations.
To drive mechanistic physiologic modeling forward, and to
make it more useful, a practical, EHR data-integrated approach
that allows for either interaction with clinical care or better
reflection of known physiological problems is necessary — for it is
through qualitative understanding of models as dynamical and
control systems [43] that actionable clinical interventions will
come. Relative to glucose/insulin regulation, in some circum-
stances, monitoring and correcting for hyperglyceimia can help
reduce mortality significantly [44] (note, the issue of how tightly to
control glucose in the ICU is complicated and controversial).
Nevertheless, correlation is not causation; the mechanistic reasons
why glucose control in ICU populations helps with outcomes is not
well understood, and thus optimal clinical interventions remain
unavailable (cf., the introduction in Moghissi et al. [45]). The
inevitable conclusion is that glucose/insulin dynamics and time
implications of those dynamics are poorly understood on longer
time scales. Moreover, the current state of glucose/insulin
physiological modeling does not have a mechanism for under-
standing the fundamental physiological problems (i.e., longer term
effects of glucose dynamics) that can suggest productive clinical
interventions (e.g., ICU glucose control and regulation). But,
again, such models cannot be developed without impetus, and that
impetus must come in the form of concrete, data-based signals.
While the data scarcity has made such signals difficult to come by,
EHR data will put the data scarcity problems behind us and
replace these problems with new signal processing problems that
must be overcome. This paper represents a step forward in this
direction by using EHR data to discover a physiologic-based signal
that is connected to physiologic-based models even in the
circumstance where direct observation of the physiological
variable does not yield a signal that can stratify the population.
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